IN8BIO, Inc.
INAB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001740279
No open-market purchases or sales by IN8BIO, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $5.35M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in IN8BIO, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +1 vs. Q2 2024
- Shares held
- 7.63M
- −59.5K (−0.8%) vs. Q2 2024
- Total value
- $2.06M
- −$4.67M (−69.4%) vs. Q2 2024
- New holders
- 6
- 7 more added
- Sold out
- 5
- 6 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $5.35M |
| Q1 2026 | 19 | $5.55M |
| Q4 2025 | 22 | $7.45M |
| Q3 2025 | 19 | $2.13M |
| Q2 2025 | 12 | $1.83M |
| Q1 2025 | 28 | $3.60M |
| Q4 2024 | 26 | $7.72M |
| Q3 2024 | 26 | $2.06M |
| Q2 2024 | 26 | $6.77M |
| Q1 2024 | 32 | $10.2M |
| Q4 2023 | 30 | $11.4M |
| Q3 2023 | 21 | $2.58M |
| Q2 2023 | 22 | $3.59M |
| Q1 2023 | 17 | $1.78M |
| Q4 2022 | 16 | $2.79M |
| Q3 2022 | 17 | $2.42M |
| Q2 2022 | 15 | $5.50M |
| Q1 2022 | 14 | $7.02M |
| Q4 2021 | 14 | $7.80M |
| Q3 2021 | 13 | $12.2M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding IN8BIO, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 85 | $23 | 0.00% | +7+9.0% | Added |
| Barclays PLC | 102 | $28 | 0.00% | +102 | New |
| Bank of America Corp | 420 | $113 | 0.00% | +154+57.9% | Added |
| HRT Financial LP | 11,252 | $3.00K | 0.00% | +439+4.1% | Added |
| HighTower Advisors, LLC | 10,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 12,000 | $3.24K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 12,350 | $3.33K | 0.00% | +12,350 | New |
| Tower Research Capital LLC (TRC) | 13,189 | $3.56K | 0.00% | +9,404+248.5% | Added |
| UBS Group AG | 26,270 | $7.09K | 0.00% | +26,270 | New |
| Jane Street Group, LLC | 29,223 | $7.89K | 0.00% | +29,223 | New |
| Northern Trust Corp | 30,005 | $8.10K | 0.00% | −46,133−60.6% | Reduced |
| Rock Creek Group, LP | 30,294 | $8.18K | 0.00% | −22,096−42.2% | Reduced |
| Overbrook Management Corp | 33,756 | $9.11K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 52,807 | $14.0K | 0.00% | +52,807 | New |
| BlackRock, Inc. | 59,216 | $16.0K | 0.00% | +59,216 | New |
| Voss Capital, LLC | 64,000 | $17.3K | 0.00% | −27,000−29.7% | Reduced |
| Texas Capital Bank Wealth Management Services Inc | 78,624 | $21.2K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 88,746 | $24.0K | 0.00% | 00.0% | Unchanged |
| Stonegate Investment Group, LLC | 180,000 | $48.6K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 329,274 | $88.9K | 0.00% | +11,904+3.8% | Added |
| Alyeska Investment Group, L.P. | 434,809 | $117.4K | 0.00% | −206,199−32.2% | Reduced |
| Ensign Peak Advisors, Inc | 829,176 | $223.9K | 0.00% | −289,090−25.9% | Reduced |
| Sigma Planning Corp | 851,280 | $229.8K | 0.01% | +251,600+42.0% | Added |
| 683 Capital Management, LLC | 1,350,304 | $364.6K | 0.04% | +759,493+128.6% | Added |
| Vanguard Group Inc | 1,423,897 | $384.5K | 0.00% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 1,674,638 | $452.2K | 0.21% | −453,360−21.3% | Reduced |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −103,302−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −69,718−100.0% | Sold out |
| Laird Norton Trust Company, LLC | 0 | $0 | 0.00% | −42,300−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −13,105−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −215−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |